Cercacor Laboratories, Inc.
USPTO PatentsView assignee record - 53 granted patents across 10 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Cercacor ranks #6,319 of 49,997 tracked US assignees by granted-patent volume, with 53 patents across 10 technology areas.
- #6,319
- of 49,997 US assignees by volume
- Top 28%
- by Innovation Score (43.5/100)
- 17.3
- avg claims per patent
- -17%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R6319 · US Corporation #6,319 · 53 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 53 grants
- UPPER-Q #6,319/49,997
- PHOTO-FINISH Beijing BOE Chatani
- CPC-FOCUS A61B · 10 areas
- INNOV-PAR 43.5/100
- CLAIMS-RICH 17.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -17% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Beijing BOE Chatani Electronics Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Cercacor’s 43.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Cercacor
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Cercacor Laboratories · this assignee
Cercacor Laboratories · this assignee
44 score
- Kumiai Chemical… · near
Kumiai Chemical… · near
44 score
- Neuboron Medtech · near
Neuboron Medtech · near
44 score
- Velo3d · near
Velo3d · near
44 score
- WD Media · near
WD Media · near
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Cercacor's Innovation Score is 43.5/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Cercacor?
Each dot is one of Cercacor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cercacor’s own 17.3 claims/patent is at or below the 18.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Cercacor's grants concentrate
Cercacor Laboratories, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (11 grants) versus a trough of 3 in 2018. By volume, Cercacor sits between Beijing BOE Chatani Electronics Co., Ltd. and Crane Payment Innovations, Inc..
Cercacor's three-year grant acceleration
Cercacor Laboratories, Inc. shows 16 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Cercacor's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Beijing BOE Chata…
Beijing BOE Chatani Electronics Co., Ltd.
53 patents
- Bemis Manufacturi…
Bemis Manufacturing Company
53 patents
- Beta Bionics
Beta Bionics, Inc.
53 patents
- Cambrios Film Sol…
Cambrios Film Solutons Corporation
53 patents
- Chegg
Chegg, Inc.
53 patents
- Cognis IP Managem…
Cognis IP Management GmbH
53 patents
- Complete Genomics
Complete Genomics, Inc.
53 patents
- Crane Payment Inn…
Crane Payment Innovations, Inc.
53 patents
- Cercacor Laborato… ◀
Cercacor Laboratories, Inc.
53 patents
What this shows Cercacor holds 53 patents at rank #6,318, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Cercacor
By rank, the assignees closest to #6,318 in granted patent volume.
- Beijing BOE Chatani Electronics Co., Ltd. #6,314 · 53 patents
- Bemis Manufacturing Company #6,315 · 53 patents
- Beta Bionics, Inc. #6,316 · 53 patents
- Cambrios Film Solutons Corporation #6,317 · 53 patents
- Chegg, Inc. #6,319 · 53 patents
- Cognis IP Management GmbH #6,320 · 53 patents
- Complete Genomics, Inc. #6,321 · 53 patents
- Crane Payment Innovations, Inc. #6,322 · 53 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Cercacor's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Cercacor, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Cercacor ranks #356 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (44 here).
Similar claim depth
Nearest assignees by average claims per patent (17.3 here).
Cercacor's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 28% higher than 72% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 11 | 20.8% |
| 2016 | 4 | 7.5% |
| 2017 | 6 | 11.3% |
| 2018 | 3 | 5.7% |
| 2019 | 5 | 9.4% |
| 2020 | 5 | 9.4% |
| 2021 | 3 | 5.7% |
| 2022 | 6 | 11.3% |
| 2023 | 7 | 13.2% |
| 2024 | 3 | 5.7% |
Which technologies does Cercacor Laboratories, Inc. patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Cercacor Laboratories, Inc.'s patent record in context - here's where to go next.
- Cercacor Laboratories, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #6,319 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Cercacor Laboratories, Inc. against Beijing BOE Chatani Electronics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 43.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.